Role of CNPase in the oligodendrocytic extracellular 2′,3′-cAMP-adenosine pathway

GLIA

Volumn 61, Issue 10, 2013, Pages 1595-1606

  Verrier, Jonathan D ^a   Jackson, Travis C ^a,b   Gillespie, Delbert G ^a   Janesko Feldman, Keri ^a   Bansal, Rashmi ^c   Goebbels, Sandra ^d   Nave, Klaus Armin ^d   Kochanek, Patrick M ^a,b   Jackson, Edwin K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^d MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

Author keywords

2 ,3 cAMP; 2 ,3 cyclic nucleotide 3 phosphodiesterase; 2 AMP; 3 AMP; Adenosine

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; ADENOSINE 2' PHOSPHATE; ADENOSINE 2',3' PHOSPHATE; ADENOSINE 3' PHOSPHATE; ADENOSINE PHOSPHATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL METABOLISM; CONCENTRATION (PARAMETERS); GENOTYPE; MOUSE; NERVE CELL CULTURE; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN METABOLISM;

2′,3′-CAMP; 2′,3′-CYCLIC NUCLEOTIDE-3′-PHOSPHODIESTERASE; 2′-AMP; 3′-AMP; ADENOSINE;

1-METHYL-3-ISOBUTYLXANTHINE; 2',3'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; ADENINE NUCLEOTIDES; ADENOSINE; ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; CELLS, CULTURED; EMBRYO, MAMMALIAN; EXTRACELLULAR FLUID; MICE; MICE, TRANSGENIC; NEURONS; OLIGODENDROGLIA; PHOSPHODIESTERASE INHIBITORS; SIGNAL TRANSDUCTION;

EID: 84882909533     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22523     Document Type: Article

References (40)

1. 2+-dependent permeability transition regulation in rat brain mitochondria by 2′, 3′-cyclic nucleotides and 2′, 3′-cyclic nucleotide 3′-phosphodiesterase. Am J Physiol Cell Physiol 296:1428-1439.
2. Beavo JA, Reifsnyder DH. 1990. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci 11:150-155.
3. Bell MJ, Kochanek PM, Carcillo JA, Mi Z, Schiding JK, Wisniewski SR, Clark RS, Dixon CE, Marion DW, Jackson E. 1998. Interstitial adenosine, inosine, and hypoxanthine are increased after experimental traumatic brain injury in the rat. J Neurotraum 15:163-170.
4. Bell MJ, Robertson CS, Kochanek PM, Goodman JC, Gopinath SP, Carcillo JA, Clark RS, Marion DW, Mi Z, Jackson EK. 2001. Interstitial brain adenosine and xanthine increase during jugular venous oxygen desaturations in humans after traumatic brain injury.[see comment]. Crit Care Med 29:399-404.
5. Chen Y, Balasubramaniyan V, Peng J, Hurlock EC, Tallquist M, Li J, Lu QR. 2007. Isolation and culture of rat and mouse oligodendrocyte precursor cells. Nat Protoc 2:1044-1051.
6. Dai SS, Zhou YG. 2011. Adenosine 2A receptor: A crucial neuromodulator with bidirectional effect in neuroinflammation and brain injury. Rev Neurosci 22:231-239.
7. Edgar JM, McLaughlin M, Werner HB, McCulloch MC, Barrie JA, Brown A, Faichney AB, Snaidero N, Nave K-A, Griffiths IR. 2009. Early ultrastructural defects of axons and axon-glia junctions in mice lacking expression of Cnp1. GLIA 57:1815-1824.
8. Eltzschig HK. 2009. Adenosine: An old drug newly discovered. Anesthesiology 111:904-915.
9. Eltzschig HK, Carmeliet P. 2011. Hypoxia and inflammation. N Engl J Med 364:656-665.
10. Eltzschig HK, Weissmuller T, Mager A, Eckle T. 2006. Nucleotide metabolism and cell-cell interactions. Methods Mol Biol 341:73-87.
11. Fern R, Waxman SG, Ransom BR. 1994. Modulation of anoxic injury in CNS white matter by adenosine and interaction between adenosine and GABA. J Neurophysiol 72:2609-2616.
12. Hagemeyer N, Goebbels S, Papiol S, Kästner A, Hofer S, Begemann M, Gerwig UC, Boretius S, Wieser GL, Ronnenberg A, Gurvich A, Heckers SH, Frahm J, Nave KA, Ehrenreich H. 2012. A myelin gene causative of a catatonia-depression syndrome upon aging. EMBO Mol Med 4:528-539.
13. Hinman JD, Chen C-D, Oh S-Y, Hollander W, Abraham CR. 2008. Age-dependent accumulation of ubiquitinated 2′, 3′-cyclic nucleotide 3′-phosphodiesterase in myelin lipid rafts. GLIA 56:118-133.
14. Jackson EK. 2011. The 2′, 3′-cAMP-adenosine pathway. Am J Physiol Renal 301:F1160-F1167.
15. Jackson EK, Gillespie DG. 2012. Extracellular 2′, 3′-cAMP and 3′, 5′-cAMP stimulate proliferation of preglomerular vascular endothelial cells and renal epithelial cells. Am J Physiol Renal Physiol 303:F954-F962.
16. 2B receptors. J Pharmacol Exp Ther 337:444-450.
17. Jackson EK, Raghvendra DK. 2004. The extracellular cyclic AMP-adenosine pathway in renal physiology. Annu Rev Physiol 66:571-99.
18. Jackson EK, Ren J, Cheng D, Mi Z. 2011b. Extracellular cAMP-adenosine pathways in the mouse kidney. Am J Physiol Renal Physiol 301:F565-F573.
19. 2B receptors. Am J Physiol Heart Circ Physiol 301:H391-H401.
20. Jackson EK, Ren J, Gillespie DG, Dubey RK. 2010a. Extracellular 2′, 3′-cyclic adenosine 5′-monophosphate is a potent inhibitor of preglomerular vascular smooth muscle cell and mesangial cell growth. Hypertension 56:151-158.
21. Jackson EK, Ren J, Mi Z. 2009. Extracellular 2′, 3′-cAMP is a source of adenosine. J Biol Chem 284:33097-33106.
22. Jackson TC, Verrier JD, Semple-Rowland S, Kumar A, Foster TC. 2010b. PHLPP1 splice variants differentially regulate AKT and PKC signaling in hippocampal neurons: characterization of PHLPP proteins in the adult hippocampus. J Neurochem 115:941-955.
23. 1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. J Cereb Blood Flow Metab 26:565-575.
24. Lappe-Siefke C, Goebbels S, Gravel M, Nicksch E, Lee J, Braun PE, Griffiths IR, Nave K-A. 2003. Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination.[see comment]. Nat Genet 33:366-374.
25. 1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death. Neuropsychopharmacology 35:1550-1559.
26. Lugnier C. 2006. Cyclic nucleotide phosphodiesterase (PDE) superfamily: A new target for the development of specific therapeutic agents. Pharmacol Ther 109:366-398.
27. Myllykoski M, Itoh K, Kangas SM, Heape AM, Kang S-U, Lubec G, Kursula I, Kursula P. 2012. The N-terminal domain of the myelin enzyme 2′, 3′-cyclic nucleotide 3′-phosphodiesterase: Direct molecular interaction with the calcium sensor calmodulin. J Neurochem 23:515-524.
28. Pedraza CE, Monk R, Lei J, Hao Q, Macklin W. 2008. Production, characterization, and efficient transfection of highly pure oligodendrocyte precursor cultures from mouse embryonic neural progenitors. GLIA 56:1339-1352.
29. Rao F, Qi Y, Murugan E, Pasunooti S, Ji Q. 2010. 2′, 3′-cAMP hydrolysis by metal-dependent phosphodiesterases containing DHH, EAL, and HD domains is non-specific: Implications for PDE screening. Biochem Biophys Res Commun 398:500-505.
30. Sprinkle TJ. 1989. 2′, 3′-cyclic nucleotide 3′-phosphodiesterase, an oligodendrocyte-Schwann cell and myelin-associated enzyme of the nervous system. Crit Rev Neurobiol 4:235-301.
31. Stone TW, Ceruti S, Abbracchio MP. 2009. Adenosine receptors and neurological disease: neuroprotection and neurodegeneration. Handb Exp Pharm 193:535-587.
32. Thompson JE, Venegas FD, Raines RT. 1994. Energetics of catalysis by ribonucleases: Fate of the 2′, 3′-cyclic phosphodiester intermediate. Biochemistry 33:7408-7414.
33. Tofovic SP, Branch KR, Oliver RD, Magee WD, Jackson EK. 1991. Caffeine potentiates vasodilator-induced renin release. J Pharmacol Exp Ther 256:850-860.
34. Verrier JD, Exo JL, Jackson TC, Ren J, Gillespie DG, Dubey RK, Kochanek PM, Jackson EK. 2011. Expression of the 2′, 3′-cAMP-adenosine pathway in astrocytes and microglia. J Neurochem 118:979-987.
35. Verrier JD, Jackson TC, Bansal R, Kochanek PM, Puccio AM, Okonkwo DO, Jackson EK. 2012. The brain in vivo expresses the 2′, 3′-cAMP-adenosine pathway. J Neurochem 122:115-125.
36. Vlkolinsky R, Cairns N, Fountoulakis M, Lubec G. 2001. Decreased brain levels of 2′, 3′-cyclic nucleotide-3′-phosphodiesterase in Down syndrome and Alzheimer's disease. Neurobiol Aging 22:547-553.
37. Walsh MJ, Murray JM. 1998. Dual implication of 2′, 3′-cyclic nucleotide 3′ phosphodiesterase as major autoantigen and C3 complement-binding protein in the pathogenesis of multiple sclerosis. J Clin Invest 101:1923-1931.
38. Weissbarth S, Maker HS, Raes I, Brannan TS, Lapin EP, Lehrer GM. 1981. The activity of 2′, 3′-cyclic nucleotide 3′-phosphodiesterase in rat tissues. J Neurochem 37:677-680.
39. Wieser GL, Gerwig UC, Adamcio B, Barrette B, Nave K-A, Ehrenreich H, Goebbels S. 2013. Neuroinflammation in white matter tracts of Cnp1 mutant mice amplied by a minor brain injury. GLIA 61:869-880.
40. Zimmermann H. 1992. 5′-Nucleotidase: Molecular structure and functional aspects. Biochem J 285:345-365.